Application of composition in preparation of medicine for treating type 2 diabetes

Abstract

The invention discloses application of a composition in preparation of a medicine for treating type 2 diabetes. The composition contains a therapeutically-effective amount of 1'-(1H-indazol-5-carbonyl)-1-isopropyl-4,6-dihydrospiro[indazol-5,4'-piperidine]-7(1H)-one and a therapeutically-effective amount of 4-[5-cyano-4-({2-fluoro-4-[1-(2-hydroxyethyl)-1H-tetrazol-5-yl]phenoxy}methyl)-1H-pyrazol-1-yl]piperidin-1-isopropyl formate which have the mass ratio of (3: 1) to (1: 3). The composition of the medicine can be used for effectively treating the type 2 diabetes.

Description

technical field

[0001] The invention relates to a medicine, in particular to the application of a composition in the preparation of a medicine for treating type 2 diabetes. Background technique

[0002] Diabetes (diabetes) is a sugar, protein, A series of metabolic disorder syndromes including fat, water and electrolytes, clinically characterized by hyperglycemia, polyuria, polydipsia, polyphagia, weight loss, etc. Blood sugar) Once it is not well controlled, it will cause complications, leading to failure and lesions of the kidneys, eyes, feet and other parts, and it cannot be cured.

[0003] Patients with type 2 diabetes do not need to rely on insulin and can use oral hypoglycemic drugs to control blood sugar, also known as non-insulin-dependent diabetes. The so-called "type 2 diabetes" is formed after a long pathological process under the action of various pathogenic factors. Due to the existence of pathogenic factors, the normal blood structure balance is destroyed, a...